Department of Cardiology and Center for Cardiological Innovation, Oslo University Hospital, Rikshospitalet, Oslo, Norway; Institute for Clinical Medicine, University of Oslo, Oslo, Norway.
Department of Cardiology and Center for Cardiological Innovation, Oslo University Hospital, Rikshospitalet, Oslo, Norway; Institute for Clinical Medicine, University of Oslo, Oslo, Norway; Institute for Surgical Research, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
Int J Cardiol. 2018 Jan 1;250:157-163. doi: 10.1016/j.ijcard.2017.07.015.
We aimed to investigate if history of vigorous exercise was associated with changes in left ventricular morphology, left ventricular function and ventricular arrhythmias (VAs) in hypertrophic cardiomyopathy genotype positive, phenotype negative (Genotype+ LVH-) and in phenotype positive (HCM LVH+).
In this cross sectional study we included 187 subjects (age 49±16years, 89(48%) female, 121(65%) HCM LVH+ and 66 (35%) Genotype+ LVH-) who answered a questionnaire on physical activity history. Exercise ≥6 metabolic equivalents was defined as vigorous. Subjects with a history of vigorous exercise ≥4h/week during ≥6years were defined as athletes. All underwent echocardiography and Holter monitoring. VAs were defined as aborted cardiac arrest, sustained or non-sustained ventricular tachycardia.
In both Genotype+ LVH- and HCM LVH+, lifetime vigorous exercise correlated with larger left ventricular end-diastolic volume (rho 0.44 and 0.38 respectively, both p<0.001). Lifetime vigorous exercise correlated with increased left ventricular mass in Genotype+ LVH- (rho 0.28, p=0.03), but not in HCM LVH+ (p=0.53). Left ventricular systolic function was similar between athletes and non-athletes in Genotype+ LVH- and HCM LVH+. HCM LVH+ athletes had lower E/e' (p=0.03) and higher e' (p=0.02) compared to non-athletes, while this difference was not observed in Genotype+ LVH-. Lifetime vigorous exercise was similar among HCM LVH+ with and without VAs (p=0.89).
Increased lifetime vigorous exercise was associated with larger left ventricular volumes in hypertrophic cardiomyopathy, but correlated to left ventricular mass only in Genotype+ LVH-. Vigorous exercise was associated with favorable diastolic function in HCM LVH+, and was not associated with VAs.
我们旨在研究剧烈运动史是否与肥厚型心肌病基因型阳性、表型阴性(Genotype+ LVH-)和表型阳性(HCM LVH+)患者左心室形态、左心室功能和室性心律失常(VA)的变化有关。
在这项横断面研究中,我们纳入了 187 名受试者(年龄 49±16 岁,89 名女性,占 48%,121 名 HCM LVH+,占 65%,66 名 Genotype+ LVH-,占 35%),他们回答了一份关于体力活动史的问卷。运动≥6 代谢当量定义为剧烈运动。每周≥4 小时、持续≥6 年的剧烈运动史定义为运动员。所有受试者均行超声心动图和动态心电图监测。VA 定义为心脏骤停、持续性或非持续性室性心动过速。
在 Genotype+ LVH-和 HCM LVH+中,终生剧烈运动与更大的左心室舒张末期容积相关(分别为 rho 0.44 和 0.38,均 p<0.001)。终生剧烈运动与 Genotype+ LVH-的左心室质量增加相关(rho 0.28,p=0.03),但与 HCM LVH+无关(p=0.53)。在 Genotype+ LVH-和 HCM LVH+中,运动员和非运动员的左心室收缩功能相似。与非运动员相比,HCM LVH+运动员的 E/e'较低(p=0.03),e'较高(p=0.02),而 Genotype+ LVH-中则无此差异。在 HCM LVH+中,有 VA 和无 VA 的患者之间的终生剧烈运动相似(p=0.89)。
在肥厚型心肌病中,增加的终生剧烈运动与更大的左心室容积相关,但仅在 Genotype+ LVH-中与左心室质量相关。剧烈运动与 HCM LVH+的有利的舒张功能相关,与 VA 无关。